Literature DB >> 9727049

A p56lck-independent pathway of CD2 signaling involves Jun kinase.

R Sunder-Plassmann1, E L Reinherz.   

Abstract

The p56 Src family non-receptor tyrosine kinase has been shown to be critical for T lymphocyte differentiation and activation. Hence in the absence of p56, T cell receptor triggered activation does not occur. We now provide evidence for a CD2-based signaling pathway which, in contrast to that of the T cell receptor, is independent of p56. CD2-mediated interleukin-2 production occurs via activation of Jun kinase in cell lines lacking p56. Jun kinase then facilitates the binding of c-Jun/c-Fos heterodimers to the AP-1 consensus site and the subsequent transcriptional activity of the interleukin-2 promoter. These data elucidate differences between TCR and CD2 signaling pathways in the same T cells.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9727049     DOI: 10.1074/jbc.273.37.24249

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  6 in total

1.  Dynamic interaction of CD2 with the GYF and the SH3 domain of compartmentalized effector molecules.

Authors:  Christian Freund; Ronald Kühne; Hailin Yang; Sunghyouk Park; Ellis L Reinherz; Gerhard Wagner
Journal:  EMBO J       Date:  2002-11-15       Impact factor: 11.598

Review 2.  Focal adhesion kinase-related protein tyrosine kinase Pyk2 in T-cell activation and function.

Authors:  Hanne L Ostergaard; Tara L Lysechko
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

3.  Identification of a proline-binding motif regulating CD2-triggered T lymphocyte activation.

Authors:  K Nishizawa; C Freund; J Li; G Wagner; E L Reinherz
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-08       Impact factor: 11.205

4.  Combining conformational flexibility and continuum electrostatics for calculating pK(a)s in proteins.

Authors:  Roxana E Georgescu; Emil G Alexov; Marilyn R Gunner
Journal:  Biophys J       Date:  2002-10       Impact factor: 4.033

Review 5.  CD2 Immunobiology.

Authors:  Christian Binder; Filip Cvetkovski; Felix Sellberg; Stefan Berg; Horacio Paternina Visbal; David H Sachs; Erik Berglund; David Berglund
Journal:  Front Immunol       Date:  2020-06-09       Impact factor: 7.561

6.  Recombinant HBsAg of the Wild-Type and the G145R Escape Mutant, included in the New Multivalent Vaccine against Hepatitis B Virus, Dramatically Differ in their Effects on Leukocytes from Healthy Donors In Vitro.

Authors:  Maria V Konopleva; Vera N Borisova; Maria V Sokolova; Tatyana A Semenenko; Anatoly P Suslov
Journal:  Vaccines (Basel)       Date:  2022-02-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.